Transendothelial Electrical Resistance

A change in Transendothelial Electrical Resistance can indicate altered barrier integrity, even when the cultured layer remains in place. Because the reading reflects ion movement through cell–cell junctions and the continuity of the monolayer, shifts may point to changes in junctional restriction or gaps within the endothelial layer. This makes TEER useful for tracking barrier disruption over an experiment.

Tight junctions strongly influence how readily ions cross between adjacent endothelial cells, so their condition contributes substantially to the measured resistance. A reading therefore provides information about junction-dependent restriction rather than cellular behavior in isolation. In blood–brain barrier models, monitoring this component helps researchers examine how inflammatory, neurotoxic, or therapeutic conditions affect the endothelial interface.

Inflammatory and neurotoxic conditions can change the electrical resistance of an endothelial monolayer by affecting junctional restriction or layer continuity. Drugs and biomaterials may also produce measurable shifts when they influence the barrier. Interpreting these responses in relation to the tested condition allows investigators to distinguish barrier formation, preservation, or disruption within a central nervous system model.

In blood–brain barrier models, the measurement provides a quantitative readout that can be followed as the endothelial layer forms or responds to experimental treatment. This helps connect cellular changes with barrier performance without requiring the layer to be disrupted for each measurement. The resulting data support investigations of disease mechanisms and conditions that modify vascular restriction in the brain.

The workflow uses cultured endothelial cells arranged as a monolayer and electrodes positioned to apply a small electrical signal across that layer. The resulting resistance is recorded and interpreted in relation to cell–cell junctions and monolayer continuity. Repeating the measurement during barrier formation or treatment enables researchers to monitor changes while preserving the cultured model.

Researchers can use TEER when they need to evaluate whether a cultured endothelial barrier forms, remains intact, or changes after exposure to an inflammatory or neurotoxic condition. The approach is also suited to testing how drugs affect vascular restriction in a brain model. Its noninvasive character supports repeated assessment during the course of an experiment.

TEER helps researchers assess how drugs and biomaterials affect the restrictive properties of endothelial barriers relevant to the central nervous system. A measured change can indicate that an intervention has modified barrier integrity or vascular permeability-related behavior. This information supports evaluation of therapeutic delivery strategies while also revealing whether the tested approach may compromise the blood–brain barrier model.

Repeated TEER measurements can document the progression of barrier formation and reveal responses to disease-related or treatment-related conditions. Because the measurement is noninvasive, investigators can follow the same cultured endothelial model across experimental stages rather than relying only on a final observation. This longitudinal perspective strengthens studies of barrier dynamics, disease mechanisms, and therapeutic effects.